Skip to search formSkip to main contentSkip to account menu

cranberry allergenic extract 50 MG/ML Injectable Solution

Known as: CRANBERRY 1 g in 20 mL PERCUTANEOUS INJECTION, SOLUTION [CRANBERRY], CRANBERRY 0.05 g in 1 mL INTRADERMAL INJECTION, SOLUTION, CRANBERRY 0.05 g in 1 mL SUBCUTANEOUS INJECTION, SOLUTION 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The exopolysaccharides (EPS) produced by Streptococcus mutans-derived glucosyltransferases (Gtfs) are essential virulence factors… 
2012
2012
Aims:  Periodontitis is an inflammatory disease of polymicrobial origin that affects the tooth‐supporting tissues. With the… 
2012
2012
Optimized purification of oligomeric proanthocyanidines (PAC) from cranberry generated PAC-1A which selectively… 
2011
2011
This study investigated the effect of A-type cranberry proanthocyanidins (AC-PACs) on osteoclast formation and bone resorption… 
Review
2010
Review
2010
Over the past decade, cranberries and their molecular components have received increasing attention from researchers in human… 
2008
2008
The purpose of this study was to investigate the effect of cranberry polyphenol fraction on mutans streptococci. Hydrophobicity… 
2008
2008
Integrated pest management (IPM) was formally introduced to the cranberry industry in 1983 through support of a scouting program… 
2007
2007
Fimbrial adhesion is a Virulence Determinant which is classified under Adhesins category of virulence factor of uropathogenic… 
1984
1984
Linsdale. Jean M" and p, Quentin Tomich 1953 A herd of mule deer: a record of observations made on the Hastings Natural History…